|
LYEL Lyell Immunopharma Inc 1806952 |
| Balance Sheet |
|
Current Assets
|
$267,304,000.00 |
|
Assets
|
$350,626,000.00 |
|
Current Liabilities
|
$36,947,000.00 |
|
Liabilities
|
$76,961,000.00 |
|
Equity
|
$273,665,000.00 |
|
Shares Out
|
23328390.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-38,510,000.00 |
|
Investing Cash Flow
|
$17,378,000.00 |
| Market Analysis |
Market Cap
|
$320,065,510.80 |
|
Price
|
$12.87 |
|
BVPS
|
11.73 |
|
PB
|
1.17 |
|
EPS
|
-1.10 |
|
PS
|
40970.48 |
|
FCF
|
$-38,599,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:29 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
|
|
|
2026-05-06 |
-1.10 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LYEL documents filed with the SEC.
LYEL Filings
Clear
